Peptide YY (3-36) Completed Phase 1 Trials for Feeding and Eating Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03490786A Dose Escalating Study to Assess the Safety and Tolerability of GT-001